Skip Navigation LinksAlzheimer'sDiseaseFunding

Chronic Disease Control Branch

​​

Alzheimer's Disease Program (ADP) Funding

State Fiscal Year (SFY) 2019-20

The tables below illustrate funding budgeted by the California Department of Public Health (CDPH) for SFY 2019-20 related to Alzheimer's disease and related dementias (ADRDs) totaling $8,827,000.

BudgetedCA Alzheimer's Disease Centers
$2,818,000
  • Funding: CA State General Fund – Effective 1984 and Ongoing
  • Purpose: To allocate and administer grants to a statewide network of 10 dementia care centers at university medical schools established to improve dementia health care delivery, provide specialized training and education to health care professionals, and advance the diagnosis and treatment of ADRDs.

 

BudgetedAlzheimer's Disease Research Awards
$3,115,000
  • Funding: CA State General Fund – Effective SFY 2018-19 and Ongoing1,2,3,4
  • Purpose: To allocate and administer research grants in connection to ADRDs.
$2,400,000
  • Funding: CA State General Fund – Effective SFY 2019-20 and Ongoing5,6
  • Purpose: To allocate and administer research grants in connection to ADRDs with a focus on women and communities of color.
$494,000
  • Funding: Tax Check-Off ADRDs Research Fund – Effective 1984 and Ongoing
  • Purpose: Allows taxpayers to designate a specified amount on state tax returns (in excess of tax liability) to be transferred to the CDPH ADRDs Research Fund.

 

BudgetedCA Healthy Brain Initiative State and Local Public Health Partnerships
$0

 

ALZHEIMER'S DISEASE PROGRAM DESCRIPTION

The CDPH ADP was established pursuant to Assembly Bill 2225 (Chapter 1601, Statutes of 1984) and was expanded pursuant to Senate Bill 139 (Chapter 303, Statutes of 1988). The mission of the ADP is to reduce the human burden and economic costs associated with ADRDs, and ultimately to assist in discovering the cause and treatment of this disease.

For more information on ADP's strategies, please visit the Alzheimer's Disease Program webpage.  

References

1. As part of the 2018 Budget Act, the CDPH ADP received $3,115,000 on an ongoing basis.

2. In State Fiscal Year (SFY) 2019-20, $240,234 of the $3,115,000 is allocated towards the Alzheimer's Disease Burden Report (#18-10623) in accordance with Senate Bill 1292.

3. In SFY 2019-20, $494,000 of Tax Check-Off ADRD Research Funds is allocated to the CDPH Alzheimer's Disease Research Awards executed in 2018-19.

4. As part of the SFY 2019 Budget Act, $45,000 was approved to be shifted from the Tax Check-Off ADRDs Research Fund, Local Assistance to State Operations on an ongoing basis to pay for the Behavioral Risk Factor Surveillance System (BRFSS) Cognitive Decline module associated with cognitive function and effects on daily living; Tax Check-Off ADRDs Research Local Assistance funding for SFY 2019-20, SFY 2020-21, SFY 2021-22,  SFY 2022-23, and SFY 2023-24  was previously allocated toward CDPH Alzheimer's Disease Research Awards executed in 2018-19.  To comply with the 2019 Budget Act, award amounts for the current Alzheimer's Disease Research Awards (RFA #19-10538) years one, two, three, four, and five have been reduced by a total of $45,000 each SFY beginning with the current SFY 2019-20. 

5. As part of the 2019 Budget Act, CDPH received $3,000,000 on an ongoing basis; $300,000 is allocated each SFY for State Operations.

6. In SFY 2019-20, a one-time shift of $300,000 from Local Assistance to State Operations took place for contracting purposes related to the Governor's Alzheimer's Prevention and Preparedness Task Force thereby reducing research funding to $2,400,000 for SFY 2019-20, and resuming to $2,700,000 annually thereafter.

7. As part of the SFY 2019 Budget Act, CDPH ADP received one-time General Fund expenditure authority of $4,500,000 to allocate grants to up to six local health jurisdictions over three SFYs beginning SFY 2019-20 to SFY 2021-22.

8. Due to circumstances surrounding the Coronavirus (COVID-19) outbreak, budget adjustments were made to allow project work to begin SFY 2020-21 instead of SFY 2019-20.

 

Page Last Updated :